Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

Go back to Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
(NASDAQ: DRMA) Delayed: 1.23 +0.06 (5.13%)
Previous Close $1.17    52 Week High
Open $1.20    52 Week Low
Day High $1.26    P/E N/A 
Day Low $1.20    EPS
Volume 49,259